These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6977032

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M.
    J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
    [Abstract] [Full Text] [Related]

  • 3. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M, Hausmann-Martinez-Pardo G, Braun-Falco O.
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [Abstract] [Full Text] [Related]

  • 4. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis.
    Goldstein R, Duvic M, Targoff IN, Reichlin M, McMenemy AM, Reveille JD, Warner NB, Pollack MS, Arnett FC.
    Arthritis Rheum; 1990 Aug; 33(8):1240-8. PubMed ID: 1975177
    [Abstract] [Full Text] [Related]

  • 5. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A.
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The type I interferon system in idiopathic inflammatory myopathies.
    Lundberg IE, Helmers SB.
    Autoimmunity; 2010 Apr; 43(3):239-43. PubMed ID: 20187702
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Preliminary report on the clinical application of anti-Jo-1 antibody].
    Dong Y, Cheng PC, Zhang NC.
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):368-9, 383. PubMed ID: 2582917
    [Abstract] [Full Text] [Related]

  • 10. [Cytoplasmic staining pattern characteristic for anti Jo-1 antibody in HEp-2 cells].
    Nagano Y, Yoshinoya S, Ohkubo A.
    Rinsho Byori; 1991 Mar; 39(3):269-72. PubMed ID: 1711130
    [Abstract] [Full Text] [Related]

  • 11. Immunoserological aspects of idiopathic inflammatory muscle disease.
    Rozman B, Bozic B, Kos-Golja M, Plesivcnik-Novljan M, Kveder T.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):722-7. PubMed ID: 11020964
    [Abstract] [Full Text] [Related]

  • 12. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
    Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F, Ollier WE, McCann LJ, Varsani H, Dunphy J, North J, Davidson JE, Juvenile Dermatomyositis Research Group (JDRG).
    Rheumatology (Oxford); 2007 Dec 25; 46(12):1786-91. PubMed ID: 18003662
    [Abstract] [Full Text] [Related]

  • 13. HLA-D related (DR) antigens in various kinds of myositis.
    Hirsch TJ, Enlow RW, Bias WB, Arnett FC.
    Hum Immunol; 1981 Oct 25; 3(2):181-6. PubMed ID: 6948801
    [Abstract] [Full Text] [Related]

  • 14. [Clinical features and misdiagnosis of anti-Jo-1 syndrome: analysis of 33 cases].
    Zheng WJ, Wei W, Tang FL.
    Zhonghua Yi Xue Za Zhi; 2003 Sep 25; 83(18):1565-8. PubMed ID: 14642109
    [Abstract] [Full Text] [Related]

  • 15. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L, Allenbach Y, Hervier B, Devilliers H, Mariampillay K, Dubourg O, Maisonobe T, Gherardi R, Mezin P, Preusse C, Stenzel W, Benveniste O.
    Brain; 2015 Sep 25; 138(Pt 9):2485-92. PubMed ID: 26198592
    [Abstract] [Full Text] [Related]

  • 16. Subacute cutaneous lupus erythematosus.
    Gilliam JN, Sontheimer RD.
    Clin Rheum Dis; 1982 Aug 25; 8(2):343-52. PubMed ID: 6754230
    [No Abstract] [Full Text] [Related]

  • 17. [Class I and II HLA antigens in patients with systemic lupus erythematosus in the south of Spain].
    Camps García MT, Ocón Sánchez P, Alonso Ortiz A, Belmonte López MA, García Portales R, Frutos Sanz MA, Guil García M, de Ramón Garrido E.
    Med Clin (Barc); 1994 May 14; 102(18):688-93. PubMed ID: 8028418
    [Abstract] [Full Text] [Related]

  • 18. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy.
    Rider LG, Gurley RC, Pandey JP, Garcia de la Torre I, Kalovidouris AE, O'Hanlon TP, Love LA, Hennekam RC, Baumbach LL, Neville HE, Garcia CA, Klingman J, Gibbs M, Weisman MH, Targoff IN, Miller FW.
    Arthritis Rheum; 1998 Apr 14; 41(4):710-9. PubMed ID: 9550481
    [Abstract] [Full Text] [Related]

  • 19. Immunogenetics of inflammatory myopathies.
    Garlepp MJ.
    Baillieres Clin Neurol; 1993 Nov 14; 2(3):579-97. PubMed ID: 8156144
    [Abstract] [Full Text] [Related]

  • 20. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies.
    Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV, Ollier WE, Cooper RG, UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC).
    Rheumatology (Oxford); 2007 Sep 14; 46(9):1411-6. PubMed ID: 17586554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.